Glucocorticoid-induced glucocorticoid-receptor expression and promoter usage is not linked to glucocorticoid resistance in childhood ALL

被引:54
作者
Tissing, Wim J. E.
Meijerink, Jules P. P.
Brinkhof, Bas
Broekhuis, Mathilde J. C.
Menezes, Renee X.
den Boer, Monique L.
Pieters, Rob
机构
[1] Erasmus Univ, Sophia Childrens Hosp, Erasmus Med Ctr, Dept Pediat Oncol Haematol, NL-3015 GJ Rotterdam, Netherlands
[2] Univ Groningen, Dept Pediat Oncol Haematol, Beatrix Childrens Hosp, NL-9700 AB Groningen, Netherlands
[3] Univ Groningen, Med Ctr, Groningen, Netherlands
[4] Leiden Univ, Dept Med Stat, Med Ctr, NL-2300 RA Leiden, Netherlands
关键词
D O I
10.1182/blood-2006-01-0261
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Glucocorticoid (GC) resistance is an adverse prognostic factor in childhood acute lymphoblastic leukemia (ALL), but little is known about causes of GC resistance. Up-regulation of the glucocorticoid receptor (GR) has been suggested as an essential step to the induction of apoplosis in leukemic cells. In this study we investigated whether baseline mRNA expression levels of the 5 different GR promoter transcripts (1A1, 1A2, 1A3, 1B, and 1C) or differences in the degree of regulation of the GR or GR promoter transcripts upon GC exposure are related to GC resistance. Therefore, mRNA levels of the 5 GR promoter transcripts and of the GR were measured by quantitative real-time reverse transcriptase-polymerase chain reaction (RT-PCR; Taqman) technology in primary ALL cells prior to and after 3, 8, and 24 hours of prednisolone exposure. GR expression is induced upon GC expo- sure in primary ALL patient samples, which is opposite to what is found in tissues in which GCs do not induce apoptosis. GC resistance in childhood ALL cannot be attributed to an inability of resistant cells to up-regulate the expression of the GR upon GC exposure, nor to differences in GR promoter usage (at baseline and upon GC exposure).
引用
收藏
页码:1045 / 1049
页数:5
相关论文
共 29 条
[1]   Effect of glucocorticoid therapy on glucocorticoid receptors in children with autoimmune diseases [J].
Andreae, J ;
Tripmacher, R ;
Weltrich, R ;
Rohde, W ;
Keitzer, R ;
Wahn, U ;
Paul, K ;
Buttgereit, F .
PEDIATRIC RESEARCH, 2001, 49 (01) :130-135
[2]   Multiple promoters exist in the human GR gene, one of which is activated by glucocorticoids [J].
Breslin, MB ;
Geng, CD ;
Vedeckis, WV .
MOLECULAR ENDOCRINOLOGY, 2001, 15 (08) :1381-1395
[3]  
de Lange P, 2001, CANCER RES, V61, P3937
[4]   Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia [J].
Den Boer, ML ;
Harms, DO ;
Pieters, R ;
Kazemier, KM ;
Göbel, U ;
Körholz, D ;
Graubner, U ;
Haas, RJ ;
Jorch, N ;
Spaar, HJ ;
Kaspers, GJL ;
Kamps, WA ;
Van der Does-Van den Berg, A ;
Van Wering, ER ;
Veerman, AJP ;
Janka-Schaub, GE .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (17) :3262-3268
[5]   DIFFERENTIAL AUTOREGULATION OF GLUCOCORTICOID RECEPTOR EXPRESSION IN HUMAN T-CELL AND B-CELL LINES [J].
DENTON, RR ;
EISEN, LP ;
ELSASSER, MS ;
HARMON, JM .
ENDOCRINOLOGY, 1993, 133 (01) :248-256
[6]  
EISEN LP, 1988, J BIOL CHEM, V263, P12044
[7]   Steroid-responsive sequences in the human glucocorticoid receptor gene 1A promoter [J].
Geng, CD ;
Vedeckis, WV .
MOLECULAR ENDOCRINOLOGY, 2004, 18 (04) :912-924
[8]   Glucocorticoid receptor alpha, beta and gamma expression vs in vitro glucocorticod resistance in childhood leukemia [J].
Haarman, EG ;
Kaspers, GJL ;
Pieters, R ;
Rottier, MMA ;
Veerman, AJP .
LEUKEMIA, 2004, 18 (03) :530-537
[9]   In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia [J].
Hongo, T ;
Yajima, S ;
Sakurai, M ;
Horikoshi, Y ;
Hanada, R .
BLOOD, 1997, 89 (08) :2959-2965
[10]   Prednisolone resistance in childhood acute lymphoblastic leukemia: Vitro-vivo correlations and cross-resistance to other drugs [J].
Kaspers, GJL ;
Pieters, R ;
Van Zantwijk, CH ;
Van Wering, ER ;
Van der Does-Van den Berg, A ;
Veerman, AJP .
BLOOD, 1998, 92 (01) :259-266